報價延遲最少15分鐘:2026/03/10 00:31 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
162.79 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
7.15/10.03
|
|
企業價值
335.13B
|
| 資產負債 |
|
每股賬面淨值
24.18
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
56.67B
|
|
每股收益
28.41
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includesoff-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue. |
